BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia
| Data(s) |
2005
|
|---|---|
| Identificador | |
| Publicador |
Informa Healthcare |
| Relação |
DOI:10.1517/13543784.14.1.89 Doggrell, Sheila (2005) BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia. Expert Opinion on Investigational Drugs, 14(1), pp. 89-91. |
| Palavras-Chave | #060100 BIOCHEMISTRY AND CELL BIOLOGY #060500 MICROBIOLOGY #111500 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES #BCR-ABL Mutants, BMS-354825, Chronic Myeloid Leukaemia, Imatinib, ECE |
| Tipo |
Journal Article |
